-
Normal and Atypical Mitosis Image Classifier using Efficient Vision Transformer
Authors:
Xuan Qi,
Dominic Labella,
Thomas Sanford,
Maxwell Lee
Abstract:
We tackle atypical versus normal mitosis classification in the MIDOG 2025 challenge using EfficientViT-L2, a hybrid CNN--ViT architecture optimized for accuracy and efficiency. A unified dataset of 13,938 nuclei from seven cancer types (MIDOG++ and AMi-Br) was used, with atypical mitoses comprising ~15. To assess domain generalization, we applied leave-one-cancer-type-out cross-validation with 5-f…
▽ More
We tackle atypical versus normal mitosis classification in the MIDOG 2025 challenge using EfficientViT-L2, a hybrid CNN--ViT architecture optimized for accuracy and efficiency. A unified dataset of 13,938 nuclei from seven cancer types (MIDOG++ and AMi-Br) was used, with atypical mitoses comprising ~15. To assess domain generalization, we applied leave-one-cancer-type-out cross-validation with 5-fold ensembles, using stain-deconvolution for image augmentation. For challenge submissions, we trained an ensemble with the same 5-fold split but on all cancer types. In the preliminary evaluation phase, this model achieved balanced accuracy of 0.859, ROC AUC of 0.942, and raw accuracy of 0.85, demonstrating competitive and well-balanced performance across metrics.
△ Less
Submitted 28 August, 2025;
originally announced September 2025.
-
Lightweight MRI-Based Automated Segmentation of Pancreatic Cancer with Auto3DSeg
Authors:
Keshav Jha,
William Sharp,
Dominic LaBella
Abstract:
Accurate delineation of pancreatic tumors is critical for diagnosis, treatment planning, and outcome assessment, yet automated segmentation remains challenging due to anatomical variability and limited dataset availability. In this study, SegResNet models, as part of the Auto3DSeg architecture, were trained and evaluated on two MRI-based pancreatic tumor segmentation tasks as part of the 2025 PANT…
▽ More
Accurate delineation of pancreatic tumors is critical for diagnosis, treatment planning, and outcome assessment, yet automated segmentation remains challenging due to anatomical variability and limited dataset availability. In this study, SegResNet models, as part of the Auto3DSeg architecture, were trained and evaluated on two MRI-based pancreatic tumor segmentation tasks as part of the 2025 PANTHER Challenge. Algorithm methodology included 5-fold cross-validation with STAPLE ensembling after focusing on an anatomically relevant region-of-interest. The Pancreatic Tumor Segmentation on Diagnostic MRI task 1 training set included 91 T1-weighted arterial contrast-enhanced MRI with expert annotated pancreas and tumor labels. The Pancreatic Tumor Segmentation on MR-Linac task 2 training set used 50 T2-weighted MR-Linac cases with expert annotated pancreas and tumor labels. Algorithm-automated segmentation performance of pancreatic tumor was assessed using Dice Similarity Coefficient (DSC), 5 mm DSC, 95th percentile Hausdorff Distance (HD95), Mean Average Surface Distance (MASD), and Root Mean Square Error (RMSE). For Task 1, the algorithm achieved a DSC of 0.56, 5 mm DSC of 0.73, HD95 of 41.1 mm, MASD of 26.0 mm, and RMSE of 5164 mm. For Task 2, performance decreased, with a DSC of 0.33, 5 mm DSC of 0.50, HD95 of 20.1 mm, MASD of 7.2 mm, and RMSE of 17,203 mm. These findings illustrate the challenges of MRI-based pancreatic tumor segmentation with small datasets, highlighting variability introduced by different MRI sequences. Despite modest performance, the results demonstrate potential for automated delineation and emphasize the need for larger, standardized MRI datasets to improve model robustness and clinical utility.
△ Less
Submitted 28 August, 2025;
originally announced August 2025.
-
Multi-Phase Automated Segmentation of Dental Structures in CBCT Using a Lightweight Auto3DSeg and SegResNet Implementation
Authors:
Dominic LaBella,
Keshav Jha,
Jared Robbins,
Esther Yu
Abstract:
Cone-beam computed tomography (CBCT) has become an invaluable imaging modality in dentistry, enabling 3D visualization of teeth and surrounding structures for diagnosis and treatment planning. Automated segmentation of dental structures in CBCT can efficiently assist in identifying pathology (e.g., pulpal or periapical lesions) and facilitate radiation therapy planning in head and neck cancer pati…
▽ More
Cone-beam computed tomography (CBCT) has become an invaluable imaging modality in dentistry, enabling 3D visualization of teeth and surrounding structures for diagnosis and treatment planning. Automated segmentation of dental structures in CBCT can efficiently assist in identifying pathology (e.g., pulpal or periapical lesions) and facilitate radiation therapy planning in head and neck cancer patients. We describe the DLaBella29 team's approach for the MICCAI 2025 ToothFairy3 Challenge, which involves a deep learning pipeline for multi-class tooth segmentation. We utilized the MONAI Auto3DSeg framework with a 3D SegResNet architecture, trained on a subset of the ToothFairy3 dataset (63 CBCT scans) with 5-fold cross-validation. Key preprocessing steps included image resampling to 0.6 mm isotropic resolution and intensity clipping. We applied an ensemble fusion using Multi-Label STAPLE on the 5-fold predictions to infer a Phase 1 segmentation and then conducted tight cropping around the easily segmented Phase 1 mandible to perform Phase 2 segmentation on the smaller nerve structures. Our method achieved an average Dice of 0.87 on the ToothFairy3 challenge out-of-sample validation set. This paper details the clinical context, data preparation, model development, results of our approach, and discusses the relevance of automated dental segmentation for improving patient care in radiation oncology.
△ Less
Submitted 18 August, 2025;
originally announced August 2025.
-
BraTS orchestrator : Democratizing and Disseminating state-of-the-art brain tumor image analysis
Authors:
Florian Kofler,
Marcel Rosier,
Mehdi Astaraki,
Ujjwal Baid,
Hendrik Möller,
Josef A. Buchner,
Felix Steinbauer,
Eva Oswald,
Ezequiel de la Rosa,
Ivan Ezhov,
Constantin von See,
Jan Kirschke,
Anton Schmick,
Sarthak Pati,
Akis Linardos,
Carla Pitarch,
Sanyukta Adap,
Jeffrey Rudie,
Maria Correia de Verdier,
Rachit Saluja,
Evan Calabrese,
Dominic LaBella,
Mariam Aboian,
Ahmed W. Moawad,
Nazanin Maleki
, et al. (12 additional authors not shown)
Abstract:
The Brain Tumor Segmentation (BraTS) cluster of challenges has significantly advanced brain tumor image analysis by providing large, curated datasets and addressing clinically relevant tasks. However, despite its success and popularity, algorithms and models developed through BraTS have seen limited adoption in both scientific and clinical communities. To accelerate their dissemination, we introdu…
▽ More
The Brain Tumor Segmentation (BraTS) cluster of challenges has significantly advanced brain tumor image analysis by providing large, curated datasets and addressing clinically relevant tasks. However, despite its success and popularity, algorithms and models developed through BraTS have seen limited adoption in both scientific and clinical communities. To accelerate their dissemination, we introduce BraTS orchestrator, an open-source Python package that provides seamless access to state-of-the-art segmentation and synthesis algorithms for diverse brain tumors from the BraTS challenge ecosystem. Available on GitHub (https://github.com/BrainLesion/BraTS), the package features intuitive tutorials designed for users with minimal programming experience, enabling both researchers and clinicians to easily deploy winning BraTS algorithms for inference. By abstracting the complexities of modern deep learning, BraTS orchestrator democratizes access to the specialized knowledge developed within the BraTS community, making these advances readily available to broader neuro-radiology and neuro-oncology audiences.
△ Less
Submitted 13 June, 2025;
originally announced June 2025.
-
BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023
Authors:
Anahita Fathi Kazerooni,
Nastaran Khalili,
Xinyang Liu,
Debanjan Haldar,
Zhifan Jiang,
Anna Zapaishchykova,
Julija Pavaine,
Lubdha M. Shah,
Blaise V. Jones,
Nakul Sheth,
Sanjay P. Prabhu,
Aaron S. McAllister,
Wenxin Tu,
Khanak K. Nandolia,
Andres F. Rodriguez,
Ibraheem Salman Shaikh,
Mariana Sanchez Montano,
Hollie Anne Lai,
Maruf Adewole,
Jake Albrecht,
Udunna Anazodo,
Hannah Anderson,
Syed Muhammed Anwar,
Alejandro Aristizabal,
Sina Bagheri
, et al. (55 additional authors not shown)
Abstract:
Pediatric central nervous system tumors are the leading cause of cancer-related deaths in children. The five-year survival rate for high-grade glioma in children is less than 20%. The development of new treatments is dependent upon multi-institutional collaborative clinical trials requiring reproducible and accurate centralized response assessment. We present the results of the BraTS-PEDs 2023 cha…
▽ More
Pediatric central nervous system tumors are the leading cause of cancer-related deaths in children. The five-year survival rate for high-grade glioma in children is less than 20%. The development of new treatments is dependent upon multi-institutional collaborative clinical trials requiring reproducible and accurate centralized response assessment. We present the results of the BraTS-PEDs 2023 challenge, the first Brain Tumor Segmentation (BraTS) challenge focused on pediatric brain tumors. This challenge utilized data acquired from multiple international consortia dedicated to pediatric neuro-oncology and clinical trials. BraTS-PEDs 2023 aimed to evaluate volumetric segmentation algorithms for pediatric brain gliomas from magnetic resonance imaging using standardized quantitative performance evaluation metrics employed across the BraTS 2023 challenges. The top-performing AI approaches for pediatric tumor analysis included ensembles of nnU-Net and Swin UNETR, Auto3DSeg, or nnU-Net with a self-supervised framework. The BraTSPEDs 2023 challenge fostered collaboration between clinicians (neuro-oncologists, neuroradiologists) and AI/imaging scientists, promoting faster data sharing and the development of automated volumetric analysis techniques. These advancements could significantly benefit clinical trials and improve the care of children with brain tumors.
△ Less
Submitted 28 June, 2025; v1 submitted 11 July, 2024;
originally announced July 2024.
-
Analysis of the 2024 BraTS Meningioma Radiotherapy Planning Automated Segmentation Challenge
Authors:
Dominic LaBella,
Valeriia Abramova,
Mehdi Astaraki,
Andre Ferreira,
Zhifan Jiang,
Mason C. Cleveland,
Ramandeep Kang,
Uma M. Lal-Trehan Estrada,
Cansu Yalcin,
Rachika E. Hamadache,
Clara Lisazo,
Adrià Casamitjana,
Joaquim Salvi,
Arnau Oliver,
Xavier Lladó,
Iuliana Toma-Dasu,
Tiago Jesus,
Behrus Puladi,
Jens Kleesiek,
Victor Alves,
Jan Egger,
Daniel Capellán-Martín,
Abhijeet Parida,
Austin Tapp,
Xinyang Liu
, et al. (80 additional authors not shown)
Abstract:
The 2024 Brain Tumor Segmentation Meningioma Radiotherapy (BraTS-MEN-RT) challenge aimed to advance automated segmentation algorithms using the largest known multi-institutional dataset of 750 radiotherapy planning brain MRIs with expert-annotated target labels for patients with intact or postoperative meningioma that underwent either conventional external beam radiotherapy or stereotactic radiosu…
▽ More
The 2024 Brain Tumor Segmentation Meningioma Radiotherapy (BraTS-MEN-RT) challenge aimed to advance automated segmentation algorithms using the largest known multi-institutional dataset of 750 radiotherapy planning brain MRIs with expert-annotated target labels for patients with intact or postoperative meningioma that underwent either conventional external beam radiotherapy or stereotactic radiosurgery. Each case included a defaced 3D post-contrast T1-weighted radiotherapy planning MRI in its native acquisition space, accompanied by a single-label "target volume" representing the gross tumor volume (GTV) and any at-risk post-operative site. Target volume annotations adhered to established radiotherapy planning protocols, ensuring consistency across cases and institutions, and were approved by expert neuroradiologists and radiation oncologists. Six participating teams developed, containerized, and evaluated automated segmentation models using this comprehensive dataset. Team rankings were assessed using a modified lesion-wise Dice Similarity Coefficient (DSC) and 95% Hausdorff Distance (95HD). The best reported average lesion-wise DSC and 95HD was 0.815 and 26.92 mm, respectively. BraTS-MEN-RT is expected to significantly advance automated radiotherapy planning by enabling precise tumor segmentation and facilitating tailored treatment, ultimately improving patient outcomes. We describe the design and results from the BraTS-MEN-RT challenge.
△ Less
Submitted 21 July, 2025; v1 submitted 28 May, 2024;
originally announced May 2024.
-
The 2024 Brain Tumor Segmentation (BraTS) Challenge: Glioma Segmentation on Post-treatment MRI
Authors:
Maria Correia de Verdier,
Rachit Saluja,
Louis Gagnon,
Dominic LaBella,
Ujjwall Baid,
Nourel Hoda Tahon,
Martha Foltyn-Dumitru,
Jikai Zhang,
Maram Alafif,
Saif Baig,
Ken Chang,
Gennaro D'Anna,
Lisa Deptula,
Diviya Gupta,
Muhammad Ammar Haider,
Ali Hussain,
Michael Iv,
Marinos Kontzialis,
Paul Manning,
Farzan Moodi,
Teresa Nunes,
Aaron Simon,
Nico Sollmann,
David Vu,
Maruf Adewole
, et al. (60 additional authors not shown)
Abstract:
Gliomas are the most common malignant primary brain tumors in adults and one of the deadliest types of cancer. There are many challenges in treatment and monitoring due to the genetic diversity and high intrinsic heterogeneity in appearance, shape, histology, and treatment response. Treatments include surgery, radiation, and systemic therapies, with magnetic resonance imaging (MRI) playing a key r…
▽ More
Gliomas are the most common malignant primary brain tumors in adults and one of the deadliest types of cancer. There are many challenges in treatment and monitoring due to the genetic diversity and high intrinsic heterogeneity in appearance, shape, histology, and treatment response. Treatments include surgery, radiation, and systemic therapies, with magnetic resonance imaging (MRI) playing a key role in treatment planning and post-treatment longitudinal assessment. The 2024 Brain Tumor Segmentation (BraTS) challenge on post-treatment glioma MRI will provide a community standard and benchmark for state-of-the-art automated segmentation models based on the largest expert-annotated post-treatment glioma MRI dataset. Challenge competitors will develop automated segmentation models to predict four distinct tumor sub-regions consisting of enhancing tissue (ET), surrounding non-enhancing T2/fluid-attenuated inversion recovery (FLAIR) hyperintensity (SNFH), non-enhancing tumor core (NETC), and resection cavity (RC). Models will be evaluated on separate validation and test datasets using standardized performance metrics utilized across the BraTS 2024 cluster of challenges, including lesion-wise Dice Similarity Coefficient and Hausdorff Distance. Models developed during this challenge will advance the field of automated MRI segmentation and contribute to their integration into clinical practice, ultimately enhancing patient care.
△ Less
Submitted 28 May, 2024;
originally announced May 2024.
-
Analysis of the BraTS 2023 Intracranial Meningioma Segmentation Challenge
Authors:
Dominic LaBella,
Ujjwal Baid,
Omaditya Khanna,
Shan McBurney-Lin,
Ryan McLean,
Pierre Nedelec,
Arif Rashid,
Nourel Hoda Tahon,
Talissa Altes,
Radhika Bhalerao,
Yaseen Dhemesh,
Devon Godfrey,
Fathi Hilal,
Scott Floyd,
Anastasia Janas,
Anahita Fathi Kazerooni,
John Kirkpatrick,
Collin Kent,
Florian Kofler,
Kevin Leu,
Nazanin Maleki,
Bjoern Menze,
Maxence Pajot,
Zachary J. Reitman,
Jeffrey D. Rudie
, et al. (97 additional authors not shown)
Abstract:
We describe the design and results from the BraTS 2023 Intracranial Meningioma Segmentation Challenge. The BraTS Meningioma Challenge differed from prior BraTS Glioma challenges in that it focused on meningiomas, which are typically benign extra-axial tumors with diverse radiologic and anatomical presentation and a propensity for multiplicity. Nine participating teams each developed deep-learning…
▽ More
We describe the design and results from the BraTS 2023 Intracranial Meningioma Segmentation Challenge. The BraTS Meningioma Challenge differed from prior BraTS Glioma challenges in that it focused on meningiomas, which are typically benign extra-axial tumors with diverse radiologic and anatomical presentation and a propensity for multiplicity. Nine participating teams each developed deep-learning automated segmentation models using image data from the largest multi-institutional systematically expert annotated multilabel multi-sequence meningioma MRI dataset to date, which included 1000 training set cases, 141 validation set cases, and 283 hidden test set cases. Each case included T2, FLAIR, T1, and T1Gd brain MRI sequences with associated tumor compartment labels delineating enhancing tumor, non-enhancing tumor, and surrounding non-enhancing FLAIR hyperintensity. Participant automated segmentation models were evaluated and ranked based on a scoring system evaluating lesion-wise metrics including dice similarity coefficient (DSC) and 95% Hausdorff Distance. The top ranked team had a lesion-wise median dice similarity coefficient (DSC) of 0.976, 0.976, and 0.964 for enhancing tumor, tumor core, and whole tumor, respectively and a corresponding average DSC of 0.899, 0.904, and 0.871, respectively. These results serve as state-of-the-art benchmarks for future pre-operative meningioma automated segmentation algorithms. Additionally, we found that 1286 of 1424 cases (90.3%) had at least 1 compartment voxel abutting the edge of the skull-stripped image edge, which requires further investigation into optimal pre-processing face anonymization steps.
△ Less
Submitted 7 March, 2025; v1 submitted 15 May, 2024;
originally announced May 2024.
-
The Brain Tumor Segmentation in Pediatrics (BraTS-PEDs) Challenge: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs)
Authors:
Anahita Fathi Kazerooni,
Nastaran Khalili,
Xinyang Liu,
Deep Gandhi,
Zhifan Jiang,
Syed Muhammed Anwar,
Jake Albrecht,
Maruf Adewole,
Udunna Anazodo,
Hannah Anderson,
Ujjwal Baid,
Timothy Bergquist,
Austin J. Borja,
Evan Calabrese,
Verena Chung,
Gian-Marco Conte,
Farouk Dako,
James Eddy,
Ivan Ezhov,
Ariana Familiar,
Keyvan Farahani,
Andrea Franson,
Anurag Gottipati,
Shuvanjan Haldar,
Juan Eugenio Iglesias
, et al. (46 additional authors not shown)
Abstract:
Pediatric tumors of the central nervous system are the most common cause of cancer-related death in children. The five-year survival rate for high-grade gliomas in children is less than 20%. Due to their rarity, the diagnosis of these entities is often delayed, their treatment is mainly based on historic treatment concepts, and clinical trials require multi-institutional collaborations. Here we pr…
▽ More
Pediatric tumors of the central nervous system are the most common cause of cancer-related death in children. The five-year survival rate for high-grade gliomas in children is less than 20%. Due to their rarity, the diagnosis of these entities is often delayed, their treatment is mainly based on historic treatment concepts, and clinical trials require multi-institutional collaborations. Here we present the CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs challenge, focused on pediatric brain tumors with data acquired across multiple international consortia dedicated to pediatric neuro-oncology and clinical trials. The CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs challenge brings together clinicians and AI/imaging scientists to lead to faster development of automated segmentation techniques that could benefit clinical trials, and ultimately the care of children with brain tumors.
△ Less
Submitted 11 July, 2024; v1 submitted 23 April, 2024;
originally announced April 2024.
-
Benchmarking the CoW with the TopCoW Challenge: Topology-Aware Anatomical Segmentation of the Circle of Willis for CTA and MRA
Authors:
Kaiyuan Yang,
Fabio Musio,
Yihui Ma,
Norman Juchler,
Johannes C. Paetzold,
Rami Al-Maskari,
Luciano Höher,
Hongwei Bran Li,
Ibrahim Ethem Hamamci,
Anjany Sekuboyina,
Suprosanna Shit,
Houjing Huang,
Chinmay Prabhakar,
Ezequiel de la Rosa,
Bastian Wittmann,
Diana Waldmannstetter,
Florian Kofler,
Fernando Navarro,
Martin Menten,
Ivan Ezhov,
Daniel Rueckert,
Iris N. Vos,
Ynte M. Ruigrok,
Birgitta K. Velthuis,
Hugo J. Kuijf
, et al. (88 additional authors not shown)
Abstract:
The Circle of Willis (CoW) is an important network of arteries connecting major circulations of the brain. Its vascular architecture is believed to affect the risk, severity, and clinical outcome of serious neurovascular diseases. However, characterizing the highly variable CoW anatomy is still a manual and time-consuming expert task. The CoW is usually imaged by two non-invasive angiographic imag…
▽ More
The Circle of Willis (CoW) is an important network of arteries connecting major circulations of the brain. Its vascular architecture is believed to affect the risk, severity, and clinical outcome of serious neurovascular diseases. However, characterizing the highly variable CoW anatomy is still a manual and time-consuming expert task. The CoW is usually imaged by two non-invasive angiographic imaging modalities, magnetic resonance angiography (MRA) and computed tomography angiography (CTA), but there exist limited datasets with annotations on CoW anatomy, especially for CTA. Therefore, we organized the TopCoW challenge with the release of an annotated CoW dataset. The TopCoW dataset is the first public dataset with voxel-level annotations for 13 CoW vessel components, enabled by virtual reality technology. It is also the first large dataset using 200 pairs of MRA and CTA from the same patients. As part of the benchmark, we invited submissions worldwide and attracted over 250 registered participants from six continents. The submissions were evaluated on both internal and external test datasets of 226 scans from over five centers. The top performing teams achieved over 90% Dice scores at segmenting the CoW components, over 80% F1 scores at detecting key CoW components, and over 70% balanced accuracy at classifying CoW variants for nearly all test sets. The best algorithms also showed clinical potential in classifying fetal-type posterior cerebral artery and locating aneurysms with CoW anatomy. TopCoW demonstrated the utility and versatility of CoW segmentation algorithms for a wide range of downstream clinical applications with explainability. The annotated datasets and best performing algorithms have been released as public Zenodo records to foster further methodological development and clinical tool building.
△ Less
Submitted 8 July, 2025; v1 submitted 29 December, 2023;
originally announced December 2023.
-
The Brain Tumor Segmentation (BraTS) Challenge 2023: Glioma Segmentation in Sub-Saharan Africa Patient Population (BraTS-Africa)
Authors:
Maruf Adewole,
Jeffrey D. Rudie,
Anu Gbadamosi,
Oluyemisi Toyobo,
Confidence Raymond,
Dong Zhang,
Olubukola Omidiji,
Rachel Akinola,
Mohammad Abba Suwaid,
Adaobi Emegoakor,
Nancy Ojo,
Kenneth Aguh,
Chinasa Kalaiwo,
Gabriel Babatunde,
Afolabi Ogunleye,
Yewande Gbadamosi,
Kator Iorpagher,
Evan Calabrese,
Mariam Aboian,
Marius Linguraru,
Jake Albrecht,
Benedikt Wiestler,
Florian Kofler,
Anastasia Janas,
Dominic LaBella
, et al. (26 additional authors not shown)
Abstract:
Gliomas are the most common type of primary brain tumors. Although gliomas are relatively rare, they are among the deadliest types of cancer, with a survival rate of less than 2 years after diagnosis. Gliomas are challenging to diagnose, hard to treat and inherently resistant to conventional therapy. Years of extensive research to improve diagnosis and treatment of gliomas have decreased mortality…
▽ More
Gliomas are the most common type of primary brain tumors. Although gliomas are relatively rare, they are among the deadliest types of cancer, with a survival rate of less than 2 years after diagnosis. Gliomas are challenging to diagnose, hard to treat and inherently resistant to conventional therapy. Years of extensive research to improve diagnosis and treatment of gliomas have decreased mortality rates across the Global North, while chances of survival among individuals in low- and middle-income countries (LMICs) remain unchanged and are significantly worse in Sub-Saharan Africa (SSA) populations. Long-term survival with glioma is associated with the identification of appropriate pathological features on brain MRI and confirmation by histopathology. Since 2012, the Brain Tumor Segmentation (BraTS) Challenge have evaluated state-of-the-art machine learning methods to detect, characterize, and classify gliomas. However, it is unclear if the state-of-the-art methods can be widely implemented in SSA given the extensive use of lower-quality MRI technology, which produces poor image contrast and resolution and more importantly, the propensity for late presentation of disease at advanced stages as well as the unique characteristics of gliomas in SSA (i.e., suspected higher rates of gliomatosis cerebri). Thus, the BraTS-Africa Challenge provides a unique opportunity to include brain MRI glioma cases from SSA in global efforts through the BraTS Challenge to develop and evaluate computer-aided-diagnostic (CAD) methods for the detection and characterization of glioma in resource-limited settings, where the potential for CAD tools to transform healthcare are more likely.
△ Less
Submitted 30 May, 2023;
originally announced May 2023.
-
The Brain Tumor Segmentation (BraTS) Challenge 2023: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs)
Authors:
Anahita Fathi Kazerooni,
Nastaran Khalili,
Xinyang Liu,
Debanjan Haldar,
Zhifan Jiang,
Syed Muhammed Anwar,
Jake Albrecht,
Maruf Adewole,
Udunna Anazodo,
Hannah Anderson,
Sina Bagheri,
Ujjwal Baid,
Timothy Bergquist,
Austin J. Borja,
Evan Calabrese,
Verena Chung,
Gian-Marco Conte,
Farouk Dako,
James Eddy,
Ivan Ezhov,
Ariana Familiar,
Keyvan Farahani,
Shuvanjan Haldar,
Juan Eugenio Iglesias,
Anastasia Janas
, et al. (48 additional authors not shown)
Abstract:
Pediatric tumors of the central nervous system are the most common cause of cancer-related death in children. The five-year survival rate for high-grade gliomas in children is less than 20\%. Due to their rarity, the diagnosis of these entities is often delayed, their treatment is mainly based on historic treatment concepts, and clinical trials require multi-institutional collaborations. The MICCA…
▽ More
Pediatric tumors of the central nervous system are the most common cause of cancer-related death in children. The five-year survival rate for high-grade gliomas in children is less than 20\%. Due to their rarity, the diagnosis of these entities is often delayed, their treatment is mainly based on historic treatment concepts, and clinical trials require multi-institutional collaborations. The MICCAI Brain Tumor Segmentation (BraTS) Challenge is a landmark community benchmark event with a successful history of 12 years of resource creation for the segmentation and analysis of adult glioma. Here we present the CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs 2023 challenge, which represents the first BraTS challenge focused on pediatric brain tumors with data acquired across multiple international consortia dedicated to pediatric neuro-oncology and clinical trials. The BraTS-PEDs 2023 challenge focuses on benchmarking the development of volumentric segmentation algorithms for pediatric brain glioma through standardized quantitative performance evaluation metrics utilized across the BraTS 2023 cluster of challenges. Models gaining knowledge from the BraTS-PEDs multi-parametric structural MRI (mpMRI) training data will be evaluated on separate validation and unseen test mpMRI dataof high-grade pediatric glioma. The CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs 2023 challenge brings together clinicians and AI/imaging scientists to lead to faster development of automated segmentation techniques that could benefit clinical trials, and ultimately the care of children with brain tumors.
△ Less
Submitted 23 May, 2024; v1 submitted 26 May, 2023;
originally announced May 2023.
-
The Brain Tumor Segmentation (BraTS) Challenge 2023: Brain MR Image Synthesis for Tumor Segmentation (BraSyn)
Authors:
Hongwei Bran Li,
Gian Marco Conte,
Qingqiao Hu,
Syed Muhammad Anwar,
Florian Kofler,
Ivan Ezhov,
Koen van Leemput,
Marie Piraud,
Maria Diaz,
Byrone Cole,
Evan Calabrese,
Jeff Rudie,
Felix Meissen,
Maruf Adewole,
Anastasia Janas,
Anahita Fathi Kazerooni,
Dominic LaBella,
Ahmed W. Moawad,
Keyvan Farahani,
James Eddy,
Timothy Bergquist,
Verena Chung,
Russell Takeshi Shinohara,
Farouk Dako,
Walter Wiggins
, et al. (44 additional authors not shown)
Abstract:
Automated brain tumor segmentation methods have become well-established and reached performance levels offering clear clinical utility. These methods typically rely on four input magnetic resonance imaging (MRI) modalities: T1-weighted images with and without contrast enhancement, T2-weighted images, and FLAIR images. However, some sequences are often missing in clinical practice due to time const…
▽ More
Automated brain tumor segmentation methods have become well-established and reached performance levels offering clear clinical utility. These methods typically rely on four input magnetic resonance imaging (MRI) modalities: T1-weighted images with and without contrast enhancement, T2-weighted images, and FLAIR images. However, some sequences are often missing in clinical practice due to time constraints or image artifacts, such as patient motion. Consequently, the ability to substitute missing modalities and gain segmentation performance is highly desirable and necessary for the broader adoption of these algorithms in the clinical routine. In this work, we present the establishment of the Brain MR Image Synthesis Benchmark (BraSyn) in conjunction with the Medical Image Computing and Computer-Assisted Intervention (MICCAI) 2023. The primary objective of this challenge is to evaluate image synthesis methods that can realistically generate missing MRI modalities when multiple available images are provided. The ultimate aim is to facilitate automated brain tumor segmentation pipelines. The image dataset used in the benchmark is diverse and multi-modal, created through collaboration with various hospitals and research institutions.
△ Less
Submitted 24 November, 2024; v1 submitted 15 May, 2023;
originally announced May 2023.
-
The Brain Tumor Segmentation (BraTS) Challenge: Local Synthesis of Healthy Brain Tissue via Inpainting
Authors:
Florian Kofler,
Felix Meissen,
Felix Steinbauer,
Robert Graf,
Stefan K Ehrlich,
Annika Reinke,
Eva Oswald,
Diana Waldmannstetter,
Florian Hoelzl,
Izabela Horvath,
Oezguen Turgut,
Suprosanna Shit,
Christina Bukas,
Kaiyuan Yang,
Johannes C. Paetzold,
Ezequiel de da Rosa,
Isra Mekki,
Shankeeth Vinayahalingam,
Hasan Kassem,
Juexin Zhang,
Ke Chen,
Ying Weng,
Alicia Durrer,
Philippe C. Cattin,
Julia Wolleb
, et al. (81 additional authors not shown)
Abstract:
A myriad of algorithms for the automatic analysis of brain MR images is available to support clinicians in their decision-making. For brain tumor patients, the image acquisition time series typically starts with an already pathological scan. This poses problems, as many algorithms are designed to analyze healthy brains and provide no guarantee for images featuring lesions. Examples include, but ar…
▽ More
A myriad of algorithms for the automatic analysis of brain MR images is available to support clinicians in their decision-making. For brain tumor patients, the image acquisition time series typically starts with an already pathological scan. This poses problems, as many algorithms are designed to analyze healthy brains and provide no guarantee for images featuring lesions. Examples include, but are not limited to, algorithms for brain anatomy parcellation, tissue segmentation, and brain extraction. To solve this dilemma, we introduce the BraTS inpainting challenge. Here, the participants explore inpainting techniques to synthesize healthy brain scans from lesioned ones. The following manuscript contains the task formulation, dataset, and submission procedure. Later, it will be updated to summarize the findings of the challenge. The challenge is organized as part of the ASNR-BraTS MICCAI challenge.
△ Less
Submitted 22 September, 2024; v1 submitted 15 May, 2023;
originally announced May 2023.
-
The ASNR-MICCAI Brain Tumor Segmentation (BraTS) Challenge 2023: Intracranial Meningioma
Authors:
Dominic LaBella,
Maruf Adewole,
Michelle Alonso-Basanta,
Talissa Altes,
Syed Muhammad Anwar,
Ujjwal Baid,
Timothy Bergquist,
Radhika Bhalerao,
Sully Chen,
Verena Chung,
Gian-Marco Conte,
Farouk Dako,
James Eddy,
Ivan Ezhov,
Devon Godfrey,
Fathi Hilal,
Ariana Familiar,
Keyvan Farahani,
Juan Eugenio Iglesias,
Zhifan Jiang,
Elaine Johanson,
Anahita Fathi Kazerooni,
Collin Kent,
John Kirkpatrick,
Florian Kofler
, et al. (35 additional authors not shown)
Abstract:
Meningiomas are the most common primary intracranial tumor in adults and can be associated with significant morbidity and mortality. Radiologists, neurosurgeons, neuro-oncologists, and radiation oncologists rely on multiparametric MRI (mpMRI) for diagnosis, treatment planning, and longitudinal treatment monitoring; yet automated, objective, and quantitative tools for non-invasive assessment of men…
▽ More
Meningiomas are the most common primary intracranial tumor in adults and can be associated with significant morbidity and mortality. Radiologists, neurosurgeons, neuro-oncologists, and radiation oncologists rely on multiparametric MRI (mpMRI) for diagnosis, treatment planning, and longitudinal treatment monitoring; yet automated, objective, and quantitative tools for non-invasive assessment of meningiomas on mpMRI are lacking. The BraTS meningioma 2023 challenge will provide a community standard and benchmark for state-of-the-art automated intracranial meningioma segmentation models based on the largest expert annotated multilabel meningioma mpMRI dataset to date. Challenge competitors will develop automated segmentation models to predict three distinct meningioma sub-regions on MRI including enhancing tumor, non-enhancing tumor core, and surrounding nonenhancing T2/FLAIR hyperintensity. Models will be evaluated on separate validation and held-out test datasets using standardized metrics utilized across the BraTS 2023 series of challenges including the Dice similarity coefficient and Hausdorff distance. The models developed during the course of this challenge will aid in incorporation of automated meningioma MRI segmentation into clinical practice, which will ultimately improve care of patients with meningioma.
△ Less
Submitted 12 May, 2023;
originally announced May 2023.
